surmount-1 tirzepatide weight loss percent 72 weeks after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Dose-equivalence reference based on pivotal

doi: 10.1111/j.1749-6632.1998.tb09913.x 21 HarrisI

Zepbound, another Tirzepatide-based drug for weight loss, is under consideration and hasnt been approved yet

Recommended Home Care Strategies Patients suffering from Lymphedema are at a greater risk of developing infections and there are some simple home care strategies that help diminish the overall risk factor

MHRA reminds healthcare professionals to advise patients of the side effects of GLP-1 agonists and to report misuse GOV.UK

Each program is tailored based on your health profile, lifestyle, and long-term goals

Consult a specialist if pain in the right side of the neck persists beyond two weeks, worsens at night, or interferes with daily activities